nodes	percent_of_prediction	percent_of_DWPC	metapath
Acitretin—RXRB—Vitamin D Metabolism—PTH—nephrolithiasis	0.0442	0.213	CbGpPWpGaD
Acitretin—Raised liver function tests—Hydrochlorothiazide—nephrolithiasis	0.0304	0.041	CcSEcCtD
Acitretin—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0296	0.143	CbGpPWpGaD
Acitretin—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0267	0.036	CcSEcCtD
Acitretin—RXRA—Vitamin D Metabolism—PTH—nephrolithiasis	0.023	0.111	CbGpPWpGaD
Acitretin—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0263	CcSEcCtD
Acitretin—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0173	0.0234	CcSEcCtD
Acitretin—Hypercholesterolaemia—Hydrochlorothiazide—nephrolithiasis	0.0149	0.02	CcSEcCtD
Acitretin—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0147	0.0198	CcSEcCtD
Acitretin—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0194	CcSEcCtD
Acitretin—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.0143	0.0193	CcSEcCtD
Acitretin—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.0128	0.0173	CcSEcCtD
Acitretin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0118	0.0569	CbGpPWpGaD
Acitretin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0158	CcSEcCtD
Acitretin—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0116	0.0157	CcSEcCtD
Acitretin—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0155	CcSEcCtD
Acitretin—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0154	CcSEcCtD
Acitretin—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.011	0.0148	CcSEcCtD
Acitretin—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0147	CcSEcCtD
Acitretin—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0109	0.0146	CcSEcCtD
Acitretin—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0146	CcSEcCtD
Acitretin—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0146	CcSEcCtD
Acitretin—CYP26A1—Biological oxidations—SLC26A1—nephrolithiasis	0.0108	0.0521	CbGpPWpGaD
Acitretin—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0145	CcSEcCtD
Acitretin—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0144	CcSEcCtD
Acitretin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0143	CcSEcCtD
Acitretin—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0141	CcSEcCtD
Acitretin—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0136	CcSEcCtD
Acitretin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.01	0.0135	CcSEcCtD
Acitretin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00956	0.0129	CcSEcCtD
Acitretin—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00942	0.0127	CcSEcCtD
Acitretin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00935	0.0126	CcSEcCtD
Acitretin—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00903	0.0122	CcSEcCtD
Acitretin—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.009	0.0121	CcSEcCtD
Acitretin—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.009	0.0121	CcSEcCtD
Acitretin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00864	0.0116	CcSEcCtD
Acitretin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00824	0.0111	CcSEcCtD
Acitretin—RXRA—renal system—nephrolithiasis	0.00822	0.163	CbGeAlD
Acitretin—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00812	0.0109	CcSEcCtD
Acitretin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00805	0.0108	CcSEcCtD
Acitretin—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00802	0.0108	CcSEcCtD
Acitretin—RBP1—renal system—nephrolithiasis	0.00798	0.158	CbGeAlD
Acitretin—RXRA—kidney—nephrolithiasis	0.00795	0.157	CbGeAlD
Acitretin—RBP1—kidney—nephrolithiasis	0.00772	0.153	CbGeAlD
Acitretin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0077	0.0104	CcSEcCtD
Acitretin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00766	0.0103	CcSEcCtD
Acitretin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00764	0.0103	CcSEcCtD
Acitretin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00764	0.0103	CcSEcCtD
Acitretin—RBP1—cortex of kidney—nephrolithiasis	0.00752	0.149	CbGeAlD
Acitretin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00749	0.0101	CcSEcCtD
Acitretin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00741	0.00999	CcSEcCtD
Acitretin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00737	0.00994	CcSEcCtD
Acitretin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00707	0.00953	CcSEcCtD
Acitretin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00706	0.00951	CcSEcCtD
Acitretin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00702	0.00946	CcSEcCtD
Acitretin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.007	0.00944	CcSEcCtD
Acitretin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00695	0.00937	CcSEcCtD
Acitretin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0068	0.00917	CcSEcCtD
Acitretin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00658	0.00887	CcSEcCtD
Acitretin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00655	0.00883	CcSEcCtD
Acitretin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00624	0.0084	CcSEcCtD
Acitretin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00614	0.00828	CcSEcCtD
Acitretin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00603	0.00812	CcSEcCtD
Acitretin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00602	0.00811	CcSEcCtD
Acitretin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00597	0.00804	CcSEcCtD
Acitretin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00594	0.00801	CcSEcCtD
Acitretin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00591	0.00796	CcSEcCtD
Acitretin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00579	0.0078	CcSEcCtD
Acitretin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.0057	0.00768	CcSEcCtD
Acitretin—RARA—renal system—nephrolithiasis	0.00567	0.112	CbGeAlD
Acitretin—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00561	0.00756	CcSEcCtD
Acitretin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00554	0.00747	CcSEcCtD
Acitretin—RARA—kidney—nephrolithiasis	0.00548	0.108	CbGeAlD
Acitretin—Cough—Hydrochlorothiazide—nephrolithiasis	0.00536	0.00722	CcSEcCtD
Acitretin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00523	0.00705	CcSEcCtD
Acitretin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00523	0.00705	CcSEcCtD
Acitretin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00523	0.00705	CcSEcCtD
Acitretin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00521	0.00702	CcSEcCtD
Acitretin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00517	0.00696	CcSEcCtD
Acitretin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00511	0.00689	CcSEcCtD
Acitretin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00501	0.00676	CcSEcCtD
Acitretin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00485	0.00653	CcSEcCtD
Acitretin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00478	0.00644	CcSEcCtD
Acitretin—RXRA—NRF2 pathway—SLC2A9—nephrolithiasis	0.00457	0.022	CbGpPWpGaD
Acitretin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00457	0.00616	CcSEcCtD
Acitretin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00453	0.00611	CcSEcCtD
Acitretin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0045	0.00607	CcSEcCtD
Acitretin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00446	0.00601	CcSEcCtD
Acitretin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00595	CcSEcCtD
Acitretin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00436	0.00587	CcSEcCtD
Acitretin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00432	0.00583	CcSEcCtD
Acitretin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00578	CcSEcCtD
Acitretin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00578	CcSEcCtD
Acitretin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00557	CcSEcCtD
Acitretin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.0041	0.00553	CcSEcCtD
Acitretin—RXRA—Biological oxidations—SLC26A1—nephrolithiasis	0.00401	0.0193	CbGpPWpGaD
Acitretin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00398	0.00537	CcSEcCtD
Acitretin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00396	0.00534	CcSEcCtD
Acitretin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00396	0.00534	CcSEcCtD
Acitretin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00369	0.00498	CcSEcCtD
Acitretin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.0036	0.00485	CcSEcCtD
Acitretin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00355	0.00478	CcSEcCtD
Acitretin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00343	0.00462	CcSEcCtD
Acitretin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00332	0.00447	CcSEcCtD
Acitretin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00319	0.0043	CcSEcCtD
Acitretin—Rash—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00426	CcSEcCtD
Acitretin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00426	CcSEcCtD
Acitretin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00423	CcSEcCtD
Acitretin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00298	0.00401	CcSEcCtD
Acitretin—RBP1—Signaling Pathways—ADCY10—nephrolithiasis	0.00294	0.0142	CbGpPWpGaD
Acitretin—RBP1—Disease—SLC26A1—nephrolithiasis	0.00271	0.013	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00255	0.0123	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00255	0.0123	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—RGS14—nephrolithiasis	0.0025	0.012	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—GRHPR—nephrolithiasis	0.00244	0.0117	CbGpPWpGaD
Acitretin—RBP1—Disease—ATP6V0A4—nephrolithiasis	0.00241	0.0116	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00227	0.011	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AGXT—nephrolithiasis	0.00217	0.0105	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00208	0.01	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00208	0.01	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.00204	0.00983	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00187	0.00899	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00187	0.00899	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—APRT—nephrolithiasis	0.00185	0.0089	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—SLC26A1—nephrolithiasis	0.00185	0.0089	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00169	0.00814	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—DGKH—nephrolithiasis	0.00169	0.00814	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00158	0.00759	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00158	0.00759	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00146	0.00706	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00146	0.00706	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00141	0.00681	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00141	0.00681	CbGpPWpGaD
Acitretin—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00133	0.00643	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—AQP1—nephrolithiasis	0.00132	0.00634	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00131	0.00633	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00131	0.00633	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00131	0.00629	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00131	0.00629	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—CHRM3—nephrolithiasis	0.00122	0.00588	CbGpPWpGaD
Acitretin—CYP26A1—Metabolism—CHRM3—nephrolithiasis	0.00119	0.00574	CbGpPWpGaD
Acitretin—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00117	0.00565	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00116	0.0056	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00116	0.0056	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—PTH—nephrolithiasis	0.00112	0.00538	CbGpPWpGaD
Acitretin—RXRA—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00104	0.00503	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00104	0.005	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000948	0.00457	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000948	0.00457	CbGpPWpGaD
Acitretin—RXRA—Metabolism—GRHPR—nephrolithiasis	0.000905	0.00436	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AGXT—nephrolithiasis	0.000807	0.00389	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000719	0.00346	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000719	0.00346	CbGpPWpGaD
Acitretin—ALB—Hemostasis—DGKH—nephrolithiasis	0.000688	0.00331	CbGpPWpGaD
Acitretin—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.000688	0.00331	CbGpPWpGaD
Acitretin—RXRA—Metabolism—SLC26A1—nephrolithiasis	0.000686	0.00331	CbGpPWpGaD
Acitretin—RXRA—Metabolism—APRT—nephrolithiasis	0.000686	0.00331	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000668	0.00322	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000668	0.00322	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000595	0.00287	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000595	0.00287	CbGpPWpGaD
Acitretin—RBP1—Signaling Pathways—SPP1—nephrolithiasis	0.000561	0.0027	CbGpPWpGaD
Acitretin—RXRA—Metabolism—AQP1—nephrolithiasis	0.000489	0.00236	CbGpPWpGaD
Acitretin—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000476	0.00229	CbGpPWpGaD
Acitretin—RXRA—Metabolism—CHRM3—nephrolithiasis	0.000442	0.00213	CbGpPWpGaD
Acitretin—ALB—Metabolism—GRHPR—nephrolithiasis	0.000413	0.00199	CbGpPWpGaD
Acitretin—ALB—Metabolism—AGXT—nephrolithiasis	0.000368	0.00177	CbGpPWpGaD
Acitretin—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000313	0.00151	CbGpPWpGaD
Acitretin—ALB—Metabolism—APRT—nephrolithiasis	0.000313	0.00151	CbGpPWpGaD
Acitretin—ALB—Metabolism—AQP1—nephrolithiasis	0.000223	0.00107	CbGpPWpGaD
Acitretin—ALB—Metabolism—CHRM3—nephrolithiasis	0.000202	0.000972	CbGpPWpGaD
